An Israeli biotech has developed an investigational, proprietary protein oral delivery (POD™) technology in the development of oral vaccines that are now only available via…
The University of Oxford conducted a study recently in collaboration with a handful of other UK research centers all supported by the UK Coronavirus Immunology…
Biotech companies in China moved swiftly during the early stages of the pandemic to develop COVID-19 vaccine products. Often in partnership with State-sponsored entities, the resulting…
Recently, the chatter online about deaths associated with COVID-19 vaccines was confirmed by the U.S. Centers for Disease Control and Prevention (CDC) between the dates…
Recently, Laura Ingraham had Yale University epidemiologist Dr. Harvey Risch, a contributor to TrialSite News, as well as researcher and author Alex Berenson on her show to…
Recently, Dr. Marty Makary, a professor at the Johns Hopkins School of Medicine, Bloomberg School of Public Health and Carey Business School, and also Editor-in-Chief at…
That’s an important question. Given mounting concern about vaccine equity on the one hand, and the true risk factor(s) on the other hand for children under…
Recently published in SSRN, a large group of prominent New York City-based researchers recently completed a study thanks to the funding from NYU Grossman School…
TrialSite reported recently that a number of countries were reporting growing so-called breakthrough infections due primarily to the Delta variant surge, but also perhaps associated…
Both Pfizer and BioNTech issued a joint press release declaring that the U.S. Food and Drug Administration (FDA) granted Priority Review Designation for the Biologics…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
